Medical Director, Dermatology (Fractional)

RevelleCareFractional Medical Director: DermatologistNon-confidential opportunity brief | October 30, 2026

Location: Remote, Canada | Engagement: FractionalSuitable for circulation to prospective clinical collaborators.

Proposed scope for discussion;not an employment offer or finalized engagement.The opportunity:RevelleCare is a Canadian company building a clinician-led prescription skin-health platformfor women. Its initial focus is hormone-related skin changes in perimenopause andmenopause, with a broader strategy spanning concerns such as acne, melasma, pigmentationand hair loss.We are seeking a dermatologist who combines clinical judgement with an interest in women’shealth, patient education and accessible digital care. This is an opportunity to help shape theclinical foundations of an emerging platform before launch, with patient safety andprofessional independence at its centre.Proposed responsibilities:

• Clinical review: Assess the evidence and clinical rationale for the proposed treatmentportfolio, including appropriate uses, limitations and alternatives.
• Patient selection and screening: Guide eligibility criteria, contraindication screening,referral triggers and identification of patients requiring in-person assessment.
• Care protocols: Help establish prescribing, monitoring, follow-up, adverse-event andescalation protocols with the participating healthcare practitioners.
• Practitioner collaboration: Provide clinical leadership and support, with oversightarrangements tailored to practitioner scope, jurisdiction and the agreed engagement.
• Pharmacy coordination: Work with Pace Pharmacy on clinical questions and anyoutstanding readiness requirements. Pace has confirmed it can use existing masterformulations and procedures for the initial five prescriptions; this role is not a request toinvent the launch formulas from scratch.
• Patient information: Review the clinical accuracy and balance of treatment education andproposed healthcare claims.
• Research input: Advise on the clinical relevance and feasibility of the proposed estriol andestradiol study. Any principal-investigator appointment would be a separate agreement.Candidate profile:We would welcome discussion with a dermatologist who has:
• Experience relevant to medical dermatology and prescription skincare.
• A strong interest in women’s skin health, including changes associated withperimenopause and menopause.
• A balanced, evidence-based approach to established treatments and emerging applications.
• Interest in virtual care and collaboration with pharmacists and other healthcarepractitioners.
• The ability to translate clinical expertise into practical protocols and clear patienteducation.Relevant Canadian licensure and the requirements for the proposed responsibilities would beconfirmed before appointment. Clinical research experience would be valuable, but the roleis not limited to candidates seeking a research appointment.Structure and boundariesThe engagement is remote, Canada-based and intended to be fractional. Time commitment,availability and deliverables will be discussed transparently and agreed in writing beforeappointment.Compensation: Equity-based compensation, with a monthly cash stipend considered basedon experience, responsibilities and the agreed time commitment. Final terms will bemutually agreed before appointment.This is an operational clinical leadership role, distinct from an occasional advisoryappointment. Clinical authority and accountability would be expressly defined, preservingindependent professional judgement. The role does not automatically include serving asevery patient’s treating dermatologist, supervising every practitioner or acting as studyprincipal investigator.RevelleCare’s Scientific Advisory Board is chaired by Dr. M. Joanne Lemieux, PhD. TheMedical Director would collaborate with, but have a different mandate from, the SAB.Expression of interestWe welcome an initial conversation about the opportunity, clinical priorities and a realisticscope.Michèle LunneyFounder & CEO | RevelleCare Inc.michele@revellecare.com506-260-2211revellecare.com